Table 1 Association of FAM3C expression with clinicopathological features in ESCC
From: Prognostic significance of FAM3C in esophageal squamous cell carcinoma
Clinical features | Cases | FAM3C mRNA expression | P value | |
|---|---|---|---|---|
low level (%) | high level (%) | |||
Age (years old) | Â | Â | Â | 0.204 |
 ≤59 | 49 | 28 (57.1 %) | 21 (42.9 %) |  |
 >59 | 58 | 26 (44.8 %) | 32 (55.2 %) |  |
Gender | Â | Â | Â | 0.954 |
 Male | 79 | 40 (50.6 %) | 39 (49.4 %) |  |
 Female | 28 | 14 (50.0 %) | 14 (50.0 %) |  |
Location | Â | Â | Â | 0.811 |
 Upper | 12 | 5 (41.7 %) | 7 (58.3 %) |  |
 Middle | 60 | 31 (51.7 %) | 29 (48.3 %) |  |
 Lower | 35 | 18 (51.4 %) | 17 (48.6 %) |  |
Differentiation | Â | Â | Â | 0.843 |
 Grade 1 | 20 | 9 (45.0 %) | 11 (55.0 %) |  |
 Grade 2 | 57 | 29 (50.9 %) | 28 (49.1 %) |  |
 Grade 3 | 30 | 16 (53.3 %) | 14 (46.7 %) |  |
pT stage | Â | Â | Â | 0.014 |
 T1-2 | 25 | 18 (72.0 %) | 7 (28.0 %) |  |
 T3-4 | 82 | 36 (43.9 %) | 46 (56.1 %) |  |
pN stage | Â | Â | Â | 0.026 |
 N0 | 56 | 34 (60.7 %) | 22 (39.3 %) |  |
 N1-3 | 51 | 20 (39.2 %) | 31 (60.8 %) |  |
TNM stage | Â | Â | Â | 0.003 |
 I-II | 60 | 38 (63.3 %) | 22 (36.7 %) |  |
 III | 47 | 16 (34.0 %) | 31 (66.0 %) |  |